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In contrast to Langerhans cells, which make interleukin
(IL)-12, differentiated macrophages that infiltrate the
epidermis 72 h after ultraviolet B (UV) irradiation
potently produce IL-10 mRNA and secrete IL-10 protein.
We asked whether differentiated UV macrophages in the
epidermis acquired their activated, IL-10hi status as a
result of entering the epidermis or as a result of encoun-
tering UV-induced changes in the dermal microenviron-
ment. In this study, sequential section immunostaining
directly showed dynamic and reciprocal changes of infilt-
rating CD11bF macrophages and CD1aF Langerhans cell
loss in human epidermis and dermis after in vivo UV
exposure in relation to the microanatomic localization
of newly appearing dermal cells that stain for IL-10
mRNA by in situ hybridization. Using quantitative reverse
transcriptase polymerase chain reaction on purified
dermal cell subsets, the first significant rise in IL-10
mRNA occurred 6 h after UV in the dermal CD11bF
(CD1–, 3–, 24–, 56–) monocytic/macrophagic population.
Significant induction of IL-10 mRNA 24 h post-UV was
limited to the CD11bF CD1– subset (p J 0.006). The
fold increase of IL-10 mRNA relative to 0 h by the
Ultraviolet-B radiation (UV) initiates a cascade ofinflammatory events that modifies the innate immunesystem in the skin, and also the cognitive immunityto antigens immunized through the skin of UV-exposed subjects. UV induction of immunosuppres-
sion for antigenic tumors (Fisher and Kripke, 1977; Noonan et al,
1981), contact allergens (Elmets et al, 1983; Yoshikawa et al, 1990;
Cooper et al, 1992), and microbial immunity (Denkins et al, 1989;
Jeevan and Kripke, 1989; Jeevan et al, 1992) through murine and
human skin has been well documented and reviewed (Kripke, 1984).
Although the exact sequence, interactions, and components of the
inflammatory cascade that are critical to UV-induced immunosuppres-
sion have not been fully elucidated, UV-induced Langerhans cell
damage or alteration (Morison et al, 1984; Simon et al, 1991; Tang and
Udey, 1992), macrophage infiltration (Cooper et al, 1985, 1986, 1993),
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CD11bF dermal monocytic/macrophagic population
peaked at 24–48 h and tapered thereafter. Intense IL-10
production by macrophages in the epidermis appeared
to follow dermal changes, with maximum production at
72 h, indicating migration/activation of this popula-
tion from the dermis, and the remainder of dermal cells,
depleted of monocyte/macrophages and Langerhans cell-
like antigen-presenting cells, showed no increase in IL-
10 at any time point post-UV. IL-10 protein-producing
CD11bF macrophages in the dermis were also docu-
mented by flow cytometry. IL-12 mRNA was differenti-
ally regulated from IL-10 after UV, in that IL-12 was
consistently downregulated in the CD11bF monocytic/
macrophagic population (p < 0.0002). Taken together,
monocytic/macrophagic cells with high IL-10 and low
IL-12 expression initially appear in the dermis as early as
6 h, and then appear in the epidermis, implicating the
dermis as the primary site of activation/signaling for IL-
10 upregulation in cutaneous antigen-presenting cells.
Key words: dermal and epidermal antigen-presenting cells/
immunoregulatory cytokines/UVB injury. J Invest Dermatol
110:31–38, 1998
DNA photoproducts (Vink et al, 1996), and soluble mediator and
cytokine dysregulation (Schwarz et al, 1986; Kupper et al, 1987; Araneo
et al, 1989; Ullrich, 1994; Kang et al, 1994; Enk et al, 1995) have been
implicated as key parallel or serial elements in the development of
immunosuppression.
Of particular interest is the idea that the changing populations of
antigen-presenting cells (APC) in the epidermal and upper dermal
compartments may be tightly linked to changes in the balance of
important cross-regulatory cytokines (IL-10 or IL-12) that can control
cutaneous sensitization. Specifically, we have shown that monocytes
that infiltrate UV-exposed skin differentiate into immunomodulatory
macrophages that are potent sources of IL-10 protein secretion (Kang
et al, 1994). By contrast, Langerhans cells, which upregulate IL-12
production upon maturation to potent dendritic APC function (Kang
et al, 1996), are depleted from the skin at the same time that the IL-
10 producing macrophages reach their peak after UV exposure.
IL-10 has well-demonstrated immunosuppressive properties. In the
mouse, IL-10 is a product of Th2 cells that selectively inhibit
proliferation, effector function, and development of Th1 cells
(Mosmann and Moore, 1993). IL-10 markedly inhibits dendritic cell-
driven interferon production by purified CD41 and CD81 T cells,
which suggests that IL-10 is inhibiting the initiation of cell-mediated
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immune responses (Macatonia et al, 1993; Ullrich, 1994; Schwarz et al,
1994; Enk et al, 1994), perhaps due to its effect on APC costimulatory
molecules (Ding et al, 1993). For instance, IL-10-treated Langerhans
cells downregulate B7–2 (Kawamura and Furue, 1995) and such
Langerhans cells are unable to induce Th1 cell proliferation but remain
capable of stimulating Th2 cell proliferation (Enk et al, 1993). Because
IL-10 production in the skin is upregulated after UV exposure (Rivas
and Ullrich, 1992; Kang et al, 1994), IL-10 may be a critical step in
keeping residual Langerhans cells and monocytic APC precursors in
UV-exposed skin in a state of low IL-12 and costimulatory molecule
expression. Interestingly, although the outcome may be similar, the
source of IL-10 in murine and human skin appears to differ: UV
induces murine keratinocytes to produce IL-10 (Enk and Katz, 1992;
Rivas and Ullrich, 1992; Enk et al, 1995); by contrast, in humans,
epidermal IL-10 is predominantly derived from melanocytes (Teunissen
et al, 1997) and macrophages (after UV) (Kang et al, 1994).
IL-12 has many reciprocal immunoregulatory actions to that of IL-
10; IL-12 appears to act directly to promote Th1 cell development
from a precursor cell, and induces interferon-γ production by T and
natural killer cells. Th1-specific immune responses to Leishmania are
induced by IL-12 (Afonso et al, 1994), and contact sensitivity induction
through the skin (and prevention of tolerance) is critically dependent
upon IL-12. Conversely, Th2 responses are inhibited by IL-12 both
in vitro and in vivo (McKnight et al, 1994); mice immunized with a
hapten-protein conjugate and treated systemically with IL-12 show a
marked inhibition of IL-4 secreting cells and suppressed production of
anti-hapten IgG1 antibody, as well as a marked enhancement of
interferon-γ-producing T cells. IL-12 and associated interferon-γ
production during immune responses have a negative feedback effect
on endogenous IL-10 production by macrophages (Chomarat et al,
1993), and finally acts positively on the production of IL-12 by
releasing the IL-10 inhibition exerted by macrophages (D’Andrea
et al, 1993).
After UV, a series of cellular and cytokine modulations are initiated
in the skin. Although the UV-triggered epidermis releases several
mediators, the dermis is also the site of several critical cellular shifts
with implications for immune outcome. We have shown that after
in vivo UV exposure of human skin, in the dermis the CD361 CD11b1
CD1– macrophage subset is expanded by infiltration and proliferation,
whereas CD11 Langerhans cell-like dendritic APC are concomitantly
depleted (Meunier et al, 1995; Gilliam et al, 1998). In this study we ask
whether the immunoregulatory cytokines, IL-10 and IL-12, undergo
modulation that can be ascribed to fluctuations in the levels of
CD11b1 CD1– CD3– CD24– CD56– macrophages and CD11 CD11b–
Langerhans cell-like APC that produce these cytokines. Our data
indicate that IL-10 induction is first detectable surprisingly early
(6–24 h) in the CD11b1 cells in the dermis of UV-exposed skin, in
association with the first detectable increase in CD11b1 mononuclear
cells in the perivasculature and papillary dermis, which precedes by
several days the peak of epidermal IL-10 at 72 h. IL-12 inhibition
among dermal CD11b1 cells was detected as early as 6 h, and was
significantly decreased by 24 h, indicating not only a depletion of
capable cells, but also an inhibition on a cell-for-cell basis. These data
place APC shifts and their cytokine productions timewise in the early
phase of UV injury, and spatially in the papillary and perivascular
dermis. Thus, both indigenous and infiltrating cells over the 6–72 h
period would be modified by this IL-10hi, IL-12lo milieu. This is
consistent with time courses of active immunosuppression (tolerance),
which indicate that skin does not become tolerogenic until 6–
48 h after UV exposure (Noonan and De Fabo, 1990; Hammerberg
et al, 1996b).
MATERIALS AND METHODS
Subjects Adult volunteers participated in the study after Institutional Review
Board approval of the protocol and informed consent. Keratomes or punch
biopsies were performed on the buttocks or hips of volunteers at different time
points after four minimal erythemal doses of UV irradiation from a bank of six
FS40 bulbs, and nonirradiated sites were used as controls.
Monoclonal antibodies (MoAb) For fractionation of cell populations, the
following antibodies were used: OKT6 [mIgG1 anti-CD1a, American Type
Culture Collection (ATCC) No. CRL 8020], Anti-CD1c, Anti-CD3, Anti-
CD24, Anti-CD56 (all were mIgG1, from Immunotech, Westbrook, ME), and
OKM1 (IgG2b, Anti-CD11b, ATCC No. CRL 8026 cell line). For flow-
cytometric analysis we used fluorescein isothiocyanate (FITC)-conjugated
OKT6 (Ortho Diagnostic Systems, Raritan, NJ), phycoerytherin (PE)-conjug-
ated OKM1, Biotin-conjugated HLA-DR (both from Becton Dickinson,
Mountain View, CA), and Avidin-conjugated Cascade Blue (Molecular Probes,
Eugene, OR). FITC-, PE-, and biotin-conjugated MoAb of corresponding
isotypes (mIgG1, mIgG2b, and biotin-mIgG2a) were used as controls. For
immunohistochemical staining, we used anti-CD11b (mIgG1, Mac1/Bear1,
Immunotech) with biotin-goat anti-mouse IgG1 (Caltag, San Francisco, CA),
and anti-CD1a (mIgG2a, Immunotech) with biotin-goat IgG (anti-mouse
IgG2a, Caltag).
Immunohistochemical staining The samples were frozen on dry ice and
stored at –80°C. After embedding in OCT (embedding medium) (Miles,
Elkhart, IN), 6 µm sections were cut and thaw mounted on Probe-On slides
(Fisher, Fairlawn, NJ), fixed with acetone, air dried, and stored at –80°C. The
slides were thawed, hydrated in phosphate-buffered saline (PBS, Amresco,
Solon, OH), blocked with 10% goat serum (Sigma, St. Louis, MO), treated
with primary antibody at a dilution of 1/100–500 for 1 h, washed in PBS three
times, treated with biotin-conjugated secondary antibody, then with peroxidase-
labeled streptavidin (Kirkegaard & Perry, Gaithersburg, MD) for 30 min–1 h,
washed with PBS three times, and then detected with diaminobenzidine
(Sigma). In some experiments, a Vectastain ABC Elite kit (Vector, Burlingame,
CA) replaced the secondary antibody. Slides were then dehydrated in an ethanol
series, and mounted in Permount.
In situ hybridization Tissue specimens from the same patients used for
immunostaining (above) were subjected to in situ hybridization as described by
Wilcox (1993) with the following modifications: biopsies were immediately
frozen on dry ice and stored at –80°C, or rinsed in PBS, fixed in freshly
prepared 4% paraformaldehyde in PBS (EM Science, Gibbstown, NJ) at 4°C
for 1 h, then filter-sterilized 15% sucrose in PBS at 4°C for 3 h before
embedding in OCT and storing at –80°C. All the following steps were carried
out with precautions to prevent RNase degradation (separate glassware and
autoclaved solutions prepared in diethylpyrocarbonate-treated water). Sections
were cut on a cryostat, thaw-mounted on RNase-free poly L-lysine coated
slides (100 µg per ml, 5000 MW) (Sigma) (Wilcox, 1993), immediately refrozen
in the cryostat and stored at –80°C with dessicant capsules. Before hybridization
with riboprobes for IL-10, integrity of the mRNA in each tissue specimen was
tested by hybridization with biotin-labeled poly dT (Research Genetics,
Huntsville, AL) as described in Montone and Tomaczewski (1993). Proteinase
K (Boehringer, Indianapolis, IN) dilutions were used to digest tissue to
determine optimum concentration for probe access with minimum distortion
of morphology. Tissue sections were hybridized for 1 h at room temperature
with the poly dT probe, washed for 1 h in 4 3 sodium citrate/chloride buffer
(SSC)/50% formamide for 1–2 h, then treated with alkaline phosphatase-
conjugated streptavidin (Boehringer) and detected with NBT/Xgal (Boehr-
inger). The slides were counterstained with 0.002% light green in 50 mM
sodium acetate, PH 4.5 (R&D, Minneapolis, MN), dehydrated with 100%
butanol, and mounted in Permount.
For in situ hybridization with riboprobes, slides were thawed, fixed in 4%
paraformaldehyde/PBS at 4°C for 10 min, washed for 5 min in 0.5 3 SSC
(RNase-free, Research Genetics) at room temperature, treated with the
appropriate proteinase K concentration determined in poly dT experiments,
washed for 10 min in 0.5 3 SSC, and prehybridized with 100 µl prehybridiza-
tion buffer/tissue section [0.3 M NaCl, 20 mM Tris, pH 8, 5 mM ethylenediam-
ine tetraacetic acid, 1 3 Denhardt’s (50 3 Denhardt’s; Research Genetics), 10%
dextran sulfate (7500, Pharmacia, Uppsala, Sweden), 50% formamide (Fisher)]
for 1–3 h at 42°C. Hybridization was performed overnight at 55°C by adding
20 µl of riboprobe plus tRNA (Boehringer) heated to 95°C, then placed on
ice (final concentration of riboprobe, 1 µg per ml; tRNA, 0.5 µg per ml) to
the droplet of prehybridization solution on each section. The next day after
washing to remove excess probe, the sections were treated with 100 µg RNase
A per ml 1 µg RNaseT1 per ml in 2 3 SSC (Boehringer) to decrease nonspecific
probe binding. This was followed by washes of 2 3 SSC (and in some
experiments, higher stringency in 0.1 3 SSC) at 55°C for 2 h. Detection of
IL-10 mRNA in situ with alkaline phosphatase-conjugated antibodies to
digoxigenin and NBT/Xgal was performed overnight according to the manufac-
turer’s instructions (Boehringer). Counterstaining was performed with light
green. The slides were then dehydrated in 100% butanol and mounted
in Permount.
Probes cDNA for IL-10 in pCRII transcription vector was used to generate
riboprobes for in situ hybridization on UV-exposed skin. Human IL-10 cDNA
representing the 500 bp Ecoli fragment of IL-10 coding sequence was a gift of
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Dr. Melany Jackson (University of Edinburgh, Edinburgh, Scotland). The
plasmid was linearized with the appropriate restriction enzymes and transcribed
with SP6 or T7 polymerases in the presence of digoxigenin-uridine triphosphate
(Genius 4 kit, Boehringer) to generate anti-sense and control sense RNA
probes. Labeling efficiency was determined by comparison on dot blots with
prelabeled standards supplied by the manufacturer. The equivalent of 1 µg
per ml labeled probe was used for each hybridization.
Microscopy and photography Images from immunostaining and in situ
hybridization experiments were obtained using a Zeiss (Thornwood, NY)
Axiophot microscope and Kodak (Rochester, NY) Ektachome 160T film.
These were scanned (Polaroid SprintScan, Cambridge, MA) and formatted as
tiff images in Adobe Photoshop and Adobe Illustration.
Cell sources
Epidermal cell suspensions Keratomes were obtained under aseptic conditions
from normal and/or UV-exposed skin and placed in Dispase (50 units per ml)
(Collaborative Biochem, Bedford, MA) overnight at 4°C. The epidermis was
removed from the dermis, incubated with 0.25% trypsin (Sigma) in Hank’s
balanced salt solution (HBSS) for 15 min at 37°C, transferred to a HBSS
solution containing 0.1% DNase (Sigma), and teased into a cell suspension.
After resuspension and filtration through nylon mesh, the epidermal cells were
collected in HBSS containing 1% fetal bovine serum (FBS).
Dermal cell suspensions After epidermis was removed, dermal sheets were further
digested in collagenase, hyaluronidase, and DNase for 2–3 h, filtered though
nylon mesh, and collected in HBSS containing 1% FBS, as described (Tse and
Cooper, 1990; Meunier et al, 1993).
Magnetic bead selection and depletion of epidermal cells To separate
specific epidermal cell populations from non-UV-exposed keratomes (C-
epidermal cell) or UV-exposed keratomes (UV-epidermal cell), epidermal cells
were prepared by magnetic immunobead selection and depletion as described
(Kang et al, 1994). In brief, epidermal cells were first reacted with a given
antibody for 30 min at 4°C, and then washed with PBS containing 1% FBS.
Positively selected cells were removed from epidermal cells by incubation of
antibody-labeled cells with magnetic beads coated with goat anti-mouse IgG
(Dynabeads M-450 Dynal, Oslo, Norway) for 30 min at 4°C, followed by
adherence to a magnet. Negatively selected cells were collected after four
washes on the magnet. The purity and number of bead-selected and depleted
cells was determined by counting with a hematocytometer and was .90% in
each experiment.
Immunomagnetic microbead selection and depletion of dermal
cells To separate specific dermal cell populations from non-UV-exposed
keratomes (C-dermal cells) or UV-exposed keratomes (UV-dermal cells), cells
were prepared by MicroBead selection and depletion (miniMACS technique,
Miltenyi Biotech, Sunnyvale, CA). In brief, cells were first incubated with a
given MoAb for 30 min at 4°C, followed by two washes, addition of 20 µl
goat-anti-mouse IgG MicroBeads with 80 µl 5 mM ethylenediamine tetraacetic
acid 0.5% BSA HBSS buffer for 107 cells, incubation for 15 min at 4°C, and
resuspension with 10 ml ethylenediamine tetraacetic acid 0.5% BSA HBSS
buffer. Clumps were precleared through nylon mesh (100 µm), followed by
centrifugation at 22°C for 10 min and resuspension with 0.5 ml ethylenediamine
tetraacetic acid 0.5% BSA HBSS buffer, and then passed through a MACS
separation column (#422–01 TYPE MS) in the presence of a magnetic field.
The depleted cells were collected, after which the column was removed from
the magnetic field and rinsed twice to collect the positively selected cell
population.
Cell surface markers and intracellular cytokine staining Staining for
intracellular IL-10 of dermal subsets was accomplished by cell suspensions being
incubated in RPMI Medium 1640 supplemented with 10% FBS or normal
human serum, L-glutamine, penicillin, and streptomycin, and with Brefeldin A
(10 µg per ml) for 15 h. After two washes with 1% FBS HBSS, heat-aggregated
human IgG was used to block nonspecific binding before staining. Each group
of 106 cells were incubated in 1% FBS HBSS 100 µl with FITC-conjugated
anti-CD11b (mIgG1) (Caltag, San Francisco, CA) at 4°C for 30 min. After
washes and fixation of the cells with 4% paraformaldehyde at 4°C for 30 min,
cells were then washed two times in permeabilization buffer (1% FBS HBSS
containing 0.1% saponin). Cells were then incubated with PE-conjugated rat
anti-human IL-10 (PE-JES3–9D7, PharMingen, San Diego, CA) for 30 min at
4°C, washed, and analyzed by flow-cytometry. FITC- or PE-conjugated MoAb
of different isotypes (mIgG1 or rIgG1) were used as controls.
RNA extraction, reverse transcriptase-polymerase chain reaction (RT-
PCR), and Southern blot analysis Cells selected or depleted by Dynabeads
or MicroBeads were subjected to RNA extraction by RNeasy Total RNA kits
(QIAGEN, Chatworth, CA) and the RNA quantitated by spectrophotometric
measurement. Subsequent cDNA, PCR, and Southern blotting is performed
as previously described (Kang et al, 1994), with some modifications. The cDNA
was synthesized from 200 ng of total RNA with 400 U Moloney-Murine
Leukemia Virus (M-MLV) reverse transcriptase (Gibco BRL, Grand Island,
NY) in 20 µl reverse transcriptase-mixture containing 4 µl of 53M-MLV
reverse transcriptase buffer, 20 U of RNase inhibitor (Promega, Madison, WI),
and 125 µM dNTP (dATP, dCTP, dGTP, dTTP) (Boehinger). The resulting
cDNA mixture was then mixed with a 60 µl PCR reaction mixture that
contained 103PCR buffer (Perkin-Elmer Cetus, Norwalk, CT) and 2 U of
Taq DNA polymerase (Gibco BRL), and 1 µl of 50 pmol of each of the human
IL-10 primers (primer 1, nucleotides 323–474 of the sense strand; primer 2,
nucleotides 649–674 of the anti-sense strand; bp 352) or each hIL-12 p40
primer (primer 1, nucleotides 822–839 of the sense strand, 59-CCACATT-
CCTACTTCTC-39; primer 2, nucleotides 1077–1060 of the anti-sense strand,
59-GTCTATTCCGTTGTGTC-39). Parallel samples were primed and ampli-
fied for β-actin. Thirty-two cycles were conducted in a QuarterBath Immersion
Thermal Cycler (Inotech, Lansing, MI) with denaturation at 94°C for 1 min,
annealing at 55°C (60°C for β-actin) for 1 min, and extension at 72°C for
2 min. For semiquantitation of cDNA, a standard curve of IL-10, IL-12, and
β-actin cDNA was amplified simultaneously with each experiment. PCR
products were first analyzed by electrophoresis, followed by Southern blot
hybridization.
To visualize the amount of cDNA in the experimental samples, 35S-dATP
radiolabeled dsDNA probes were prepared using a Prime-a-Gene Labeling
System (Promega). Quantitation of PCR cDNA products in the hybridized
bands was performed with a PhosphorImager (Molecular Dynamics, Sunnyvale,
CA) that determined the amount of β-emission activity in each band. The β-
emission activity in each band was converted to the concentration of cDNA
PCR product by linear regression of the radioactivity of the cDNA standard
curve against the cDNA concentration used as the cDNA template in the
standard curve PCR reaction. Experiments were used only if the correlation
coefficient was greater than 0.95, and the quantity of PCR product was greater
than 0.01 pg cDNA per mg mRNA.
RESULTS
Time course and microanatomic localization of immunopathol-
ogic changes in the epidermis and dermis after in vivo UV
exposure: increased CD11bF macrophages with in situ IL-10
upregulation and reduced CD1aF Langerhans cells To begin
to correlate UV-induced immunosuppression with temporal and spatial
changes in immune cell trafficking and production of immunoregulatory
cytokines such as IL-10, we used immunostaining for macrophages
and Langerhans cells and in situ hybridization for IL-10 in sequential
sections to study the in vivo dynamic changes of the skin after
UV exposure.
At baseline, CD11b1 cells are not detectable in the epidermis, but
large macrophagic and dendritic cells are present in the papillary dermis
and perivasculature (Fig 1a, 0 h, arrow). By 24 h after in vivo UV,
occasional CD11b1 cells are present in the epidermis (Fig 1a, 24 h,
arrow), and both intensity and density of dermal CD11b expression
appear increased among large histiocytic dermal cells. By 72 h, the
upper epidermis is disrupted and edematous, with CD11b1 cells present
throughout the epidermis (Fig 1a, 72 h, arrow). Dermal infiltration
is prominent in the interstitium and perivasculature (Fig 1a, 72 h,
arrowheads).
IL-10 in situ hybridization on baseline normal skin reveals specific
hybridization (relative to sense probe) limited to occasional individual
epidermal cells (Fig 1b, 0 h). After UV, however, specific hybridization
to IL-10 mRNA-producing cells was evident in both the epidermis
and the dermis (Fig 1b). Intensely positive single cells in the epidermis
were distributed in a scattered pattern in the damaged mid-epidermis
and the regenerating lower epidermis (Fig 1b, arrows), similar to that
of the CD11b1 cells. In the upper papillary dermis, IL-10-positive
individual large cells were clearly more numerous and darker than in
control dermis (Fig 1b, 72 h). In addition, keratinocytes in some areas
demonstrated positivity with the IL-10 anti-sense probe. Double
staining to detect both the RNA and the CD11b protein was not
possible technically, so a definitive identification of cell types producing
IL-10 mRNA could not be accomplished with these methods alone,
and was instead addressed as described below.
For comparison, the CD1a1 population of Langerhans cells is also
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Figure 1. Localization of induced CD11bF cells, IL-10 mRNA-
producing cells, and Langerhans cells in the epidermis and the dermis,
24 and 72 h after UV exposure. (a) After exposure to four minimal erythemal
doses, increasing numbers of CD11b (Mac-1)1 macrophages are seen in the
epidermis of buttock skin. In unexposed skin (0 h), Mac-11 cells are in the
papillary dermis and are located in the dermis around vessels (→). By 24 h,
isolated Mac-11 cells are in the epidermis, and at 72 h, numerous Mac-11 cells
infiltrate the epidermis (→), which shows prominent UV damage (hematoxylin
counterstain). (b) IL-10 expression by keratinocytes and by mononuclear cells
is increased after four minimal erythemal doses of UV by in situ hybridization
with DIG-labeled anti-sense IL-10 riboprobes. Positive cells stain a blue-black
color (→). At 72 h, there are IL-101 cells in the epidermis that show increased
signal relative to nearby IL-101 keratinocytes, consistent with infiltrating
CD11b1 mononuclear cell IL-10 expression. DIG-labeled sense riboprobes
show no specific labeling (middle figure) (methyl green counterstain). (c) After
four minimal erythemal doses of UV exposure to buttock skin, CD1a1
Langerhans cells (→) disappear from the epidermis by 72 h. At 24 h, the
numbers of epidermal Langerhans cells appear to be decreased and the
morphology altered (fewer dendrites) (hematoxylin counterstain). In the last
figures of parts (a)–(c), the solid line identifies the basement membrane zone.
Scale bar, 175 µm.
visualized in the same tissue. Relative to the normal pattern of
Langerhans cells (Fig 1c, 0 h), skin 24 h after UV demonstrates
decreased numbers of mid-epidermal Langerhans cells, and a change
in their morphology (loss of dendrites) (Fig 1c). By 72 h, few if any
CD1a1 Langerhans cells remain in either the epidermal or the dermal
compartment (Fig 1c).
Taken together, these images indicate that CD11b1 macrophages
have already clearly infiltrated into the epidermis 24 h post-UV
irradiation (Fig 1a, arrows) and can be identified in large numbers in
the dermis with parallel upregulation of IL-10 mRNA expression
(Fig 1b) at a time when CD1a1 Langerhans cells are reciprocally and
markedly decreased in number (Fig 1c).
Demonstration of rapid (6–24 h) HLA-DRF CD11bF mono-
cytes (Mo)/macrophages (Mph) infiltration in human dermis
after UV exposure Although our previous study revealed that, by
3 d after UV exposure, the HLA-DR1 CD11b1 (CD361) dermal
macrophage subset was significantly expanded (37.5% of 72 h DR1
UV-dermal cells versus 17.3% of 0 h DR1 control dermal cells)
(Meunier et al, 1995), the above immunohistology would suggest a
more rapid time course of infiltration than expected. Therefore, we
used three-color staining with OKM1 (CD11b), anti-CD1a, c, and
anti-HLA-DR MoAb for flow cytometry on time-coursed dermal cell
suspensions. This also allowed us to exclude any CD11b1 cells that
were not HLA-DR1, which allows selection of monocytic cells and
exclusion of neutrophils. Indeed, as suggested in Fig 1(a), the DR1
CD11b1 subpopulation was expanded as early as 6 h after UV exposure
Table I. Rapid infiltration of DRF CD11bF monocytes/
macrophages and loss of CD1aF Langerhans cells at early
time points in human dermis after UV exposure
DR1 CD11b1 CD1a1
0 h 20.6 6 0.41a 6.2 6 1.6
6 h 28.4 6 2.7 9.7 6 5
24 h 39.4 6 2.4 1.1 6 0.1
aPercentage of DR1 population in dermal cell suspensions from keratomed strips, n 5 2.
(28.4 6 2.7% of DR1 dermal cell 6 h after UV, relative to 20.6 6 0.4%
of normal DR1 dermal cells; Table I, n 5 2). By 24 h, the DR1
CD11b1 population had almost doubled to 39.4 6 2.4%, which
indicates that DR1 CD11b1 cells in the dermis actually reach a plateau
level by 24 h after UV, which is sustained at least through 72 h. This
is in contrast to the epidermis, where peak levels of macrophages do
not appear until 72 h (Cooper et al, 1985). The quantitative cell
suspension findings also elaborate on the immunolocalization data on
CD11 Langerhans cells: although the dermal DR1 CD1a11c1 sub-
population was perhaps slightly increased at 6 h (triggered migration?)
(9.7 6 5% relative to 6.2 6 1.6% of normal DR1 dermal cells), by
24 h the dermal CD11 population dropped to 1.1% of UV-dermal cell
(Table I). Thus, the early (6–24 h) increase in CD11b1 cells is indeed
that of DR1 cells (not polymorphonuclear cells), and the loss of DR1
CD1a1,c1 Langerhans cell-like/dendritic cells in the dermis follows
closely upon the initial leukocytic infiltration after UVB.
IL-10 mRNA expression by dermal DRF CD11bF monocytes/
macrophages relative to epidermal DRF CD11bF monocytes/
macrophages was markedly induced and peaked as early as 24 h
post-UV exposure We have shown that, relative to blood monocytes
prior to skin infiltration, CD11b1 macrophages infiltrating human epi-
dermis 72 h after in vivo UV exposure potently produce IL-10 (Kang
et al, 1994). Based upon the early time course of dermal infiltration, and
the presence of IL-10 mRNA-producing cells in the dermis by in situ
hybridization (Fig 1b), we asked if the differentiated UV macrophages
in the epidermis acquired their activated IL-10hi status in the dermis as a
result of UV-induced changes in the dermal environment, rather than as
a result of signals encountered in the epidermis. Dermal cell suspensions
were separated into monocytic/macrophagic cells that had been depleted
of lymphoid-dendritic cells that could potentially express CD11b by
sequential negative and then positive selection (CD11b1 CD1a–1c–
CD3– CD24– CD56–), the CD1a11c1 CD31 CD241 CD561, the first
step population, contains mainly the Langerhans cell-like dermal APC
and some dermal T cells, whereas the remaining CD11b– CD1a1c–
CD3– CD24– CD56– population (remainder dermal cells) represents
mesenchymal fibroblasts and stromal dendrocytes, endothelial cells, etc.
Among the three dermal fractions, significantly increased IL-10 mRNA
mapped only to the CD11b1 monocyte/macrophage subset at 24 h (n 5
8) 657 6 266 relative to 25.9 6 9.2 pg cDNA/mgRNA in the normal
dermal CD11b1 monocyte/macrophage population (n 5 12) (p 5
0.006, Table II). The CD11 Langerhans cell and lymphocyte fraction
also demonstrated increased IL-10 mRNA, but the magnitude was less
and inconsistent (Table II). Remainder dermal cells showed no increase
in IL-10 (Table II).
The time course of IL-10 mRNA upregulation by dermal cells is
shown in Fig 2. IL-10 mRNA in CD11b1 CD1– UV-dermal cells was
initially detectable as early as 6 h post-UV, remained elevated through
48 h, and then dropped at 72 h (Fig 2, expressed as the fold increase
relative to CD11b1 CD1– dermal cell from the control dermis of the
same subject). Interestingly, the drop in dermal IL-10 mRNA at 72 h
correlated with the appearance in the epidermis of CD11b1 cells with
very high IL-10 mRNAlevels (Fig 3). Thus, the increased IL-10 mRNA
expression in the skin by RT-PCR and by in situ hybridization (Fig 1b)
provides an anatomic and cell subset correlation between infiltration of
CD11b1 cells and the induction of IL-10 in the skin post-UVB exposure.
IL-10 and IL-12 p40 mRNA are differentially regulated in
dermal CD11bF monocytes/macrophages 24 h post-in vivo UV
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Table II. IL-10 mRNA is significantly induced in dermal
monocytic/macrophagic cells as early as 24 h post-UV
exposure
Control UV exposed (n 5 8)
(n 5 12)
CD11b1 monocytic/macrophagic cellsa 26 6 9b 657 6 266 (p 5 0.006)
CD1a1 Langerhans cells & rare T cells, 27 6 14 119 6 74
B cells, and natural killer cellsc
Remainder dermal cellsd ,1 ,1
aDermal cell suspensions from keratome strips separated by sequential absorption via
immunomagnetic beads to first remove Langerhans cells, T cells, B cells, and natural
killer cells, and then to positively select CD11b1 monocytic-macrophagic cells.
bpg cDNA per mg mRNA.
cDermal cell suspensions as above, positively selected mainly for CD1a1 dendritic
APC (dermal Langerhans cells) as well as occasional lymphoid cells which would
theoretically express CD11b.
dDermal cells remaining after the above selections – fibroblasts, endothelial cells,
stromal dendrocytes, etc.
Figure 2. IL-10 mRNA is predominantly upregulated in dermal
CD11bF CD1– monocytes/macrophages after in vivo UV exposure. The
time course of IL-10 mRNA expression of dermal cell subsets (CD11b1 CD1a–
1c– CD3– CD24– CD56– monocytes/macrophages (Mo/Mph), *CD1a1,c1
CD31 CD241 CD561 Langerhans cells and rare T cells, B cells, natural killer
cells, and CD11b– CD1a–1c– CD3– CD24– CD56– remainder cells) is expressed
as fold increase. All p values were calculated based on the fold increases between
CD11b1 monocytes/macrophages (Mo/Mph) and CD11 Langerhans cells/
lymphoid. Error bars, SEM (n 5 3–8).
Figure 3. IL-10 mRNA is initially upregulated in the dermal CD11bF
monocytes/macrophages and is followed by epidermal CD11bF
monocytes/macrophages. A time course of IL-10 mRNA expression of
dermal CD11b1 monocytes/macrophages relative to epidermal CD11b1
monocytes/macrophages is expressed as a fold increase of each cell preparation’s
IL-10 pg cDNA per mg mRNA (from standard curve), relative to the level
obtained in baseline normal skin. Error bars, SEM (n 5 3–8).
Figure 4. IL-10 mRNA is upregulated and IL-12 p40 mRNA is
downregulated in dermal CD11bF monocytic cells after UV. IL-10 and
IL-12 p40 mRNA expression by dermal CD11b1 monocytes/macrophages
after 24 h in vivo UV exposure. CD11b1, CD1a–1c–, CD3–, CD24–, and CD56–
dermal cells were fractionated by microbeads and then total mRNA was
extracted, subjected to RT-PCR, Southern blot analysis, hybridized with 35S-
labeled probes, and analyzed by PhosphorImager (see Materials and Methods).
Figure 5. IL-10 and IL-12 p40 mRNA are differentially induced in
dermal monocytes/macrophages 24 h post-in vivo UV exposure. The
groups of dermal cells were separated, mRNA was then extracted and subjected
to RT-PCR and Southern blot analysis, semiquantitated by PhosphorImager as
mentioned before, and expressed as fold increase. *p value is calculated based
on raw data relative to the controls, **p value is based on the fold changes of
IL-10 relative to IL-12 p40 mRNA of CD11b1 monocytes/macrophages
population. Error bars, SEM (n 5 4–8).
exposure The above results suggest that temporal change in the
immunoregulatory cytokine environment of the dermis after UV
exposure is related to the change of cell populations. Because IL-12 is
a reciprocal immunoregulatory cytokine for IL-10, and the CD1a1,c1
population is an important APC cell subset in terms of IL-12 production
(Kang et al, 1996), the temporal production of IL-12 p40 mRNA was
studied after separation of dermal cells into CD1a1,c1 Langerhans
cell-like/dendritic cells (n 5 5) (without lymphoid cells), into CD11b1
CD1a–, c– CD3– CD24– CD56– monocytes/macrophages (n 5 8), and
into the remainder dermal cells (n 5 4). A Southern blot of IL-10 and
IL-12 PCR products from the same CD11b1 dermal cell population
of an individual is shown in Fig 4. IL-10 mRNA is detectable at 6 h
and is markedly enhanced 24 h post-in vivo UV exposure. Interestingly
and by contrast, CD11b1 cell IL-12 p40 started to decrease at 6 h and
was markedly reduced by 24 h (Fig 4). When quantitated and expressed
as grouped data, the induction of IL-10 relative to baseline skin in
CD11b1 cells was significant (53.7-fold increase) (p 5 0.006), as was
the decrease in IL-12 mRNA (6.8-fold decrease) (Fig 5), indicating
36 KANG ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 6. IL-10 intracellular protein is induced in CD11bF monocytes/
macrophages after UV exposure as determined by flow cytometry.
Intracellular IL-10 in UV-exposed dermal cells, as determined by flow cytometry.
Based upon isotype control staining (a, d) gates were set to select CD11b1 cells
in control dermis (b, encircled population) or dermis 48 h after UV exposure
(e, encircled population). The CD11b1 monocyte/macrophage containing
population was then further analyzed by binding of rat–anti-human IL-10 to
CD11b1 cells in normal dermal cells, in which only 0.7% of cells bind anti-
IL-10 (c, far upper-right gate); 80% of CD11b1 cells in UV-dermal cells brightly
express IL-10 protein (f, far upper right). Log 90Ls indicates log 90 light scatter
of encircled (not shown) dermal cells in suspension.
Table III. Increased ratio of dermal IL-10/IL-12 of
CD11bFCD1a– monocytes/macrophages, but not CD1aF
Langerhans cells 24 h after UV exposure
IL-10a (n) IL-12a (n) IL-10/IL-12
CD1a1 Langerhans cells
Normal 27 6 14 (12) 1.9 6 1.0 (5) 14.2
UV 119 6 74 (8) 8.2 6 4.9 (5) 14.5
CD11b1 CD1a– monocytic/macrophagic cells
Normal 26 6 9 (12) 40.3 6 3.5 (5) 0.65
UV 657 6 266 (8) 6.2 6 3.8 (5) 106.0
apg cDNA per mg mRNA.
selective upregulation of IL-10 over IL-12 (p , 0.0002). In the CD1a1,
c1 Langerhans cell-like dermal subset, IL-10 mRNA was increased
16.9-fold, as compared with a variable mean 6.5-fold increase of IL-
12 p40 mRNA. When normalized to cell number, rather than expressed
as fold increase, it is apparent that the ratio of IL-10 to IL-12 in dermal
Langerhans cells was unchanged after UV (Table III, UV/N IL-10/
IL-12 5 14.5/14.2 5 1.02). By contrast, CD11b1 CD1a– monocytes/
macrophages dermal cells markedly increased the IL-10/IL-12 ratio
[Table III, UV/N (IL-10/IL-12) 5 106/0.65 5 163]. These data
indicate differential mRNA regulation in these two cell populations.
Although in dermal Langerhans cells IL-12 had increased, on a per
cell basis, from 1.9 to 8.2 pg cDNA mRNA per mg (Table III), the
percentage of CD11 Langerhans cells in UV-dermal cells in the tissue
had decreased to only 1.1%, as compared with CD1–CD11b1 DR1
dermal cells that had increased to 39% of UV-dermal cells, the relative
magnitude of the contribution of IL-12 in this population must
be minimal, particularly in light of the concomitant increase in IL-10.
Likewise, neither IL-10 nor IL-12 p40 mRNA were induced in the
remainder dermal cell subset. Taken together, IL-10 and IL-12 p40
mRNA are differentially induced in dermal monocytes/macrophages,
with a predominant expression of IL-10 mRNA 24 h post-UV
exposure.
IL-10 induction in the CD11bF monocyte/macrophage subset
post-UV exposure is reflected as IL-10 protein by intracellular
staining To corroborate protein production in the CD11b1 mono-
cyte/macrophage subset post-UV exposure, anti-CD11b MoAb-con-
jugated with FITC and anti-IL-10 MoAb-conjugated with PE (see
Materials and Methods) were used to identify cell surface molecule and
intracellular protein. Because IL-10 mRNA was significantly enhanced
either at 24 h or at 48 h post-UV exposure, the 48 h time point was
selected for the study of protein production. The IL-10-producing
cells of the CD11b1 monocytes/macrophages in UV dermal cells
demonstrated a clear shift in PE fluorescence upon replacement of
isotype rat IgG1 with rat IgG1 anti-human IL-10 (Fig 6). The
percentage of CD11b1 IL-101-producing cells in the CD11bhi popula-
tion of 48 h post-UV exposure was up to 80%.
DISCUSSION
The skin microenvironment induced after UV irradiation creates a
complex set of cellular and mediator changes in which immunosuppres-
sion, antigen specific tolerance, and inflammatory injury evolve in an
hours–days time frame. Previous studies in both mice and humans
showed that UV-irradiated skin is characterized by a dramatic loss of
the epidermal (Bergstresser et al, 1980; Aberer et al, 1981) and dermal
Langerhans cell populations (Meunier et al, 1995), and by the infiltration
of inflammatory leukocytes (Cooper et al, 1986, 1993; Jun et al, 1989;
Meunier et al, 1995). Sequential section immunostaining directly and
clearly shows the dynamic and reciprocal changes of CD11b1 macro-
phages influx and CD1a1 Langerhans cells loss in human epidermis
and dermis after in vivo UV exposure, in relation to the microanatomic
localization of newly appearing cells that stain intensely for IL-10
mRNA by in situ hybridization (Fig 1b). We have previously shown
that CD11b1 macrophages that infiltrate human epidermis 72 h after
in vivo UV exposure potently produce and secrete IL-10 (Kang et al,
1994); our findings here trace the earliest appearance of IL-10-
producing cells, both by immunopathology and by cell identity, to the
dermis in the first 24 h after UV injury. We found that the numbers
of CD11b1 macrophages had already increased 6 h post-UV exposure
and that these cells already demonstrate upregulated IL-10 mRNA by
RT-PCR at this early time point. These data are consistent with the
in situ hybridization microanatomic localization of IL-10, and further
localize selective significant IL-10 production in the dermis to the
CD11b1 macrophages and not to the other cell types in the dermis
(Fig 2). Intense IL-10 production by macrophages in the epidermis
appeared to follow dermal changes, with maximum production at 72 h
(Fig 3). IL-10 mRNA expression in macrophages after in vivo UV
exposure is also corroborated by intracellular IL-10 protein detected
by flow cytometry. Taken together, these findings indicate that the
infiltration of CD11b1 macrophages and the microenvironmental
alteration to a milieu predominated by IL-10, a well-known immuno-
suppressive immunoregulatory cytokine, occurs rapidly after UV expo-
sure and is already in place in the dermis as early as the first 24 h.
IL-12 is an immunoregulatory cytokine with many functional
activities reciprocal to IL-10: it can function as a mediator and adjuvant
for the induction of contact sensitivity in vivo (Muller et al, 1995); it
can inhibit the production of IL-10 in allergen-specific human CD41
T lymphocytes (Marshall et al, 1995); and it can overcome UV-induced
immune suppression by preventing the induction of suppressor T cells
(Schmitt et al, 1995). Therefore, determination of IL-12 p40 mRNA
in parallel with IL-10 mRNA can give us insights into the balance of
changes of cell populations and their associated immunoregulatory
cytokine profiles in the micromilieu of the skin after UV exposure.
Our data show a clear switch in the cytokines produced by dermal
CD11b1 CD1a– CD1c– cells present in normal dermis as compared
with those produced by infiltrating or in situ-activated macrophages:
IL-12 is consistently decreased (Figs 4, 5), as early as 24 h after UV,
at the same time that IL-10 is increased. Interestingly, dermal CD11
Langerhans cell-like dendritic cells remaining in UV-exposed skin
(24 h) are also induced to increase their IL-10 (although not statistically
significant, p 5 0.12) (Fig 5). Because the number of residual
Langerhans cells was only one-fortieth that of macrophages (Table I),
the absolute proportion of IL-10 in the dermis contributed by Langer-
hans cells is likely to be low. In the context of engaging a T lymphocyte,
however, CD11 APC IL-10 induction after UV may be relevant to
T cell activation outcome. The fact that IL-12 was not inhibited in
the residual CD11 population (Fig 5), but was markedly inhibited in
the IL-10hi CD11b1 macrophage population, taken together with the
finding that IL-12 reverses UV-immune suppression (Schmitt et al,
1995), may indicate that the number and intensity of T lymphocyte
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interactions with these Langerhans cells is insufficient to counterbalance
interactions with IL-12 deficient and 40-fold more numerous macro-
phages, if antigen is encountered in the 6–72-h period after UV. This,
in fact, is the peak time for induction of tolerance (Hammerberg et al,
1996b). Thus, the fact that, in addition to IL-12 depletion, IL-10 is
substantially increased, provides further evidence that the skin is
essentially changed to an immunosuppressive milieu after UV exposure.
IL-10 dominance may also favor resolution of the inflammatory
response after UV.
UV results in inflammatory injury associated with a sequential and
complex immunomodulatory process. After UV irradiation of the skin,
circulating leukocytes, such as monocytes, migrate from activated blood
vessels (i.e., via E-selectin, an adhesion molecule on endothelial
surfaces) (Walsh and Murphy, 1992), begin to traffic into the dermis
and epidermis (Hammerberg et al, 1996a), and are involved in both
immune suppression and epidermal injury (Hammerberg et al, 1996a).
These leukocytes likely obtain several signals leading to their IL-10hi,
IL-12lo status, such as from extracellular matrix ligation of their β1
integrin (Lin et al, 1995)1 and from other cytokines, e.g., tumor
necrosis factor-α (Walsh, 1995) (an IL-10 potentiator for monocytes/
macrophages; Wanidworanun and Strober, 1993), which is released
rapidly by mast cells in UV-exposed skin (Rauterberg et al, 1993). Our
data showing a rapid and very early infiltration and IL-10 induction
of monocytes/macrophages in the dermis and later in the epidermis
after UV (Fig 3), are in agreement with this scenario. The creation of
an IL-10 high, IL-12 deficient state in the skin appears consistent with
the immunosuppressive nature of skin following UV exposure, and
the tissue’s need to limit inflammatory injury responses.
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